Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention: Recommendations of the HDL Forum1 1 Affiliation details for individual members of the HDL Forum are available in the Acknowledgments section.

Author： Juan F. Ascaso  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.5, 2004-01, pp. : 299-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3841-3857

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Dyslipidemia in the Metabolic Syndrome: Recommendations of the Spanish HDL-Forum

By Ascaso Juan  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 1, 2007-01 ,pp. : 39-58

Adis International

Access to resources Recommend Favorite

Micronized Fenofibrate in Dyslipidemia: A Focus on Plasma High-Density Lipoprotein Cholesterol (HDL-C) Levels

By Sharpe M.   Ormrod D.   Jarvis B.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia

By Nakou ES   Filippatos TD   Kiortsis DN   Derdemezis CS   Tselepis AD   Mikhailidis DP   Elisaf MS  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3151-3158

Informa Healthcare

Access to resources Recommend Favorite

Optimal Therapy of Low Levels of High Density Lipoprotein-Cholesterol

By Kashyap M.L.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 53-65

Adis International

Access to resources Recommend Favorite